Company page

Impedimed Limited

Impedimed Limited, trading under the ticker IPD, is a public company based in Australia with a market capitalization of approximately AUD 9.89 million. The company focuses on developing innovative medical technologies, particularly in the field of lymphoedema management. Impedimed aims to improve patient outcomes through its advanced diagnostic and monitoring solutions.